BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33001540)

  • 1. Cross verification of independent dose recalculation, log files based, and phantom measurement-based pretreatment quality assurance for volumetric modulated arc therapy.
    Han C; Yi J; Zhu K; Zhou Y; Ai Y; Zheng X; Xie C; Jin X
    J Appl Clin Med Phys; 2020 Nov; 21(11):98-104. PubMed ID: 33001540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
    Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
    J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 4-Hz log files and secondary Monte Carlo dose calculation as patient-specific quality assurance for VMAT prostate plans.
    Szeverinski P; Kowatsch M; Künzler T; Meinschad M; Clemens P; DeVries AF
    J Appl Clin Med Phys; 2021 Jul; 22(7):235-244. PubMed ID: 34151502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-institutional initiative on patient-related quality assurance: Independent computational dose verification of fluence-modulated treatment techniques.
    Teichmann T; Salz H; Schwedas M; Schilz J; Wolf U; Walke M; Kornhuber C; Berger R; Schröder D; Hourle M; Peil T; Tümmler H; Wiezorek T; Wittig A
    Z Med Phys; 2020 May; 30(2):155-165. PubMed ID: 31980303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
    Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
    J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
    Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
    J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
    Han C; Yu W; Zheng X; Zhou Y; Gong C; Xie C; Jin X
    J Radiat Res; 2018 Sep; 59(5):669-676. PubMed ID: 30085157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of machine log files/MC-based treatment planning and delivery QA as compared to ArcCHECK QA.
    Stanhope CW; Drake DG; Liang J; Alber M; Söhn M; Habib C; Willcut V; Yan D
    Med Phys; 2018 Jul; 45(7):2864-2874. PubMed ID: 29676463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
    Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
    J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
    Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
    Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of analytical anisotropic algorithm and the two dose reporting modes of Acuros XB dose calculation algorithm in volumetric modulated arc therapy of carcinoma lung and carcinoma prostate.
    Gopalakrishnan Z; Bhasi S; P R; Menon SV; B S; Thayil AG; Nair RK
    Med Dosim; 2022 Autumn; 47(3):280-287. PubMed ID: 35690544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
    Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
    J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent recalculation outperforms traditional measurement-based IMRT QA methods in detecting unacceptable plans.
    Kry SF; Glenn MC; Peterson CB; Branco D; Mehrens H; Steinmann A; Followill DS
    Med Phys; 2019 Aug; 46(8):3700-3708. PubMed ID: 31152568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
    Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
    Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
    Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
    J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent calculation-based verification of volumetric-modulated arc therapy-stereotactic body radiotherapy plans for lung cancer.
    Ono T; Mitsuyoshi T; Shintani T; Tsuruta Y; Iramina H; Hirashima H; Miyabe Y; Nakamura M; Matsuo Y; Mizowaki T
    J Appl Clin Med Phys; 2020 Jul; 21(7):135-143. PubMed ID: 32391645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the performance of two different types of commercial software programs for 3D patient dose reconstruction for prostate cancer patients: Machine log files vs. machine log files with EPID images.
    Kadoya N; Kon Y; Takayama Y; Matsumoto T; Hayashi N; Katsuta Y; Ito K; Chiba T; Dobashi S; Takeda K; Jingu K
    Phys Med; 2018 Jan; 45():170-176. PubMed ID: 29472083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A virtual phantom for patient-specific QA On A 1.5T MR-linac.
    Ji M; Li Z; Tian Y; Zhang K; Li M; Chen Y
    J Appl Clin Med Phys; 2024 May; 25(5):e14264. PubMed ID: 38252813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Log file-based patient dose calculations of double-arc VMAT for head-and-neck radiotherapy.
    Katsuta Y; Kadoya N; Fujita Y; Shimizu E; Majima K; Matsushita H; Takeda K; Jingu K
    Phys Med; 2018 Apr; 48():6-10. PubMed ID: 29728230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Specific Quality Assurance Using Monte Carlo Dose Calculation and Elekta Log Files for Prostate Volumetric-Modulated Arc Therapy.
    Katsuta Y; Kadoya N; Fujita Y; Shimizu E; Matsunaga K; Sawada K; Matsushita H; Majima K; Jingu K
    Technol Cancer Res Treat; 2017 Dec; 16(6):1220-1225. PubMed ID: 29334027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.